1. Torstensen TA, Ljunggren AE, Meen HD, Odland E, Mowinckel P, Geijerstam S. Efficiency and costs of medical exercise therapy, conventional physiotherapy and self exercise in patients with chronic low back pain: a pragmatic, randomized, single-blinded, controlled trial with 1 year follow-up. Spine 1998;23:2616–24. 2. Borenstein DG. Epidemiology, etiology, diagnostic evaluation and treatment of low back pain. Curr Opin Rheumatol 2001;13:128–34. 3. Frank JW, Brooker AS, DeMaio SE, et al. Disability resulting from occupational low back pain: part II. What do we know about secondary prevention?A review of the scientific evidence on prevention after disability begins. Spine 1996;21:2018–27. 4. Frank JW, Kerr MS, Brooker AS, et al. Disability resulting from occupational low back pain: part I. What do we really know about primary prevention?A review of the scientific evidence on prevention before disability begins. Spine 1996;21:2008–17. 5. Kvien TK, Viktil K. Pharmacotherapy for regional musculoskeletal pain. Best Pract Res Clin Rheumatol 2003;17:137-50. 6. Cohen SP, Mullings R, Abdi S. The pharmacologic treatment of muscle pain. Anesthesiology 2004 Aug; 101 (2): 495-526 7. Celik B, Er U, Simsek S, Altug T, Bavbek M.; Effectiveness of lumbar zygapophysial joint blockage for low back pain; Turk Neurosurg. 2011;21(4):467-70. doi: 10.5137/1019-5149. 8. Beebe FA, Barkin RL, Barkin S.; A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions; Am J Ther. 2005 Mar-Apr;12(2):151-71. 9. Morlion B.; Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components; Curr Med Res Opin. 2011 Jan;27(1):11-33. 10. Van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM; Cochrane Back Review Group. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration; Spine (Phila Pa 1976). 2003 Sep 1;28(17):1978-92. 11. Anacardio R, Perilli O, Pagnanelli F, Bartolini S, Gentile MM, Mazzeo P, Carlucci G.; Physicochemical compatibility between thiocolchicoside injections (miotens) and pharmaceutical products frequently used for combined therapy; Farmaco. 2002 Nov;57(11):925-30. 12. Pifferi G.; Chemical-physical compatibility of thiocolchicoside and nonsteroidal anti-inflammatory drugs; Boll Chim Farm. 1993 Jun;132(6):203-9. 13. Deyo RA.; Drug therapy for back pain. which drugs help which patients?; Spine (Phila Pa 1976). 1996 Dec 15;21(24):2840-9; discussion 2849-50. 14. Sandouk P, Chappey O, Bouvier d'Yvoire M, et al: Pharmacokinetics of thiocolchicoside in humans using a specific radioimmunoassay. Ther Drug Monit 1995; 17:544-548. 15. Biziere K, Huguet F, Narcisse G, et al: Affinity of thiocolchicoside and thiocolchicoside analogues for the postsynaptic GABA receptor site. Eur J Pharmacol 1981; 75:167-168. 16. Weinling E, Sandouk P, Debray M, et al: Single- and repeated- dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers. Int J Clin Pharmacol Ther 1999; 37:503-509 17.Jambroers JM: Review of the toxicology, pharmacodynamics and pharmacokinetics of thiocolchicoside, a GABA-agonist muscle relaxant with anti-inflammatory and analgesic actions. Acta Therapeutica 1987;13:221-250. 18.Balduini W, Cimino M, Depoortere H, et al: Characterization of (3H)thiocolchicoside binding sites in rat spinal cord and cerebral cortex. Eur J Pharmacol 1999; 376:149-157. 19.Cimino M, Marini P, Cattabeni F. Interacción de tiocolchicosido con el receptor de glicina en la médula espinal y el tronco cerebral; Eur J Pharmacol. 1996 Dec 27;318(1):201-4. 20.Balano KB. ; Anti-inflammatory drugs and myorelaxants. Pharmacology and clinical use in musculoskeletal disease; Prim Care. 1996 Jun;23(2):329-34. 21.Borenstein DG, Lacks S, Wiesel SW.; Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm.; Clin Ther. 1990 Mar-Apr;12(2):125-31. 22.Berry H, Hutchinson DR.; Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice; J Int Med Res 1988 Mar-Apr;16(2):83-91. 23.Aglas F, Fruhwald FM, Chlud K.; Results of efficacy study with diclofenac/orphenadrine infusions in patients with musculoskeletal diseases and functional disorders; Acta Med Austriaca, 1998;25(3):86-90. 24.Tüzün F, et al. Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back pain. Joint Bone Spine. 2003; 70 (5): 356-361 25.Capra C: Attivita analgesica del tiocolchicoside. Fitoterapia 1967a; 38:66-70. 26.Capra C: Attivita anti-infiammatoria del tiocolchicoside. Fitoterapia 1967; 38:16-21. 27.Ketenci A., Ozcan E., Karamursel S. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain. Int J Clin Pract. 2005; vol 59(iss 7): p 764-770. 537483. 28.Ketenci A, Basat H, Esmaeilzadeh S.; The efficacy of topical thiocolchicoside in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study. Agri. 2009 Jul;21(3):95-103. 29.Cisneros G, Friere E, Vega B; Eficacia comparada del tiocolchicósido en el manejo del dolor agudo secundario a espasmo muscular, Servicio de Emergencia, Hospital Enrique Garcés, Quito, Ecuador, http://www.portalesmedicos.com/publicaciones/articles/3506/1/Eficacia-comparada-del-tiocolchicosido-en-el-manejo-del-dolor-agudo-secundario-a-espasmo-muscular.html, ultimo ingreso 26-02-2012.
Versión para impresión